CCCC icon

C4 Therapeutics
CCCC

Overview Fund Activity

83 hedge funds and large institutions have $64.5M invested in C4 Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
-17
Holders Change %
-17%
% of All Funds
1.32%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
7
Increased
30
Reduced
32
Closed
23
Calls
$24K
Puts
$30K
Net Calls
-$6K
Net Calls Change
-$154K

Top Buyers

1
ACH
ArrowMark Colorado Holdings
Colorado
$4.42M
2
ACM
Aquilo Capital Management
California
$3.7M
3
LCM
Lynx1 Capital Management
Puerto Rico
$1.9M
4
AQR Capital Management
AQR Capital Management
Connecticut
$2.03M
5
M&T Bank
M&T Bank
New York
$260K

Top Sellers

1
Millennium Management
Millennium Management
New York
$2.17M
2
WA
Wasatch Advisors
Utah
$11.6M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$4.07M
4
GCP
GSA Capital Partners
United Kingdom
$0
5
Citadel Advisors
Citadel Advisors
Florida
$733K
Name Holding Trade Value Shares
Change 		Shares
Change %
SEI Investments
101
SEI Investments
Pennsylvania
– -$30.8K -11,191 Closed
EGM
102
Engineers Gate Manager
New York
– -$30K -10,900 Closed
EAM
103
Erste Asset Management
Austria
– -$29.4K -10,700 Closed
New York State Common Retirement Fund
104
New York State Common Retirement Fund
New York
– -$1K -320 Closed
1 2 3 4
5